头颈癌根治性调强放疗后胃造瘘管留存率与持续时间:5年队列研究
本研究评估头颈癌患者放疗后胃造瘘管(G-tube)的留存率、持续时间及临床预测因素。纳入977例接受根治性调强放疗(IMRT)的III/IV期患者,结果显示放疗后1年和5年G-tube留存率分别为7.1%和4.8%,总体中位留置时间为63天,下咽癌患者留置时间最长。
要点
- 放疗后1年和5年G-tube留存率分别为7.1%和4.8%。
- 总体中位G-tube留置时间为63天(95%CI: 56-70)。
- 下咽癌患者中位留置时间最长(126天,95%CI: 77-256)。
核心结论
- 在提供预防性G-tube的机构中,IMRT后1至5年每年G-tube使用率无差异。
- 所有患者IMRT后中位G-tube留置时间为63天,下咽癌患者留置时间最长。
研究设计与样本
- 回顾性队列研究,纳入977例接受根治性IMRT的III/IV期头颈癌患者(鼻咽、口咽、下咽、喉或原发灶不明)。
- 平均年龄60.6±11.6岁,男性804例(82.3%),IV期764例(78.2%),口咽原发618例(63.3%)。
主要发现
- IMRT后1年和5年G-tube留存率分别为7.1%和4.8%。
- 总体中位G-tube留置时间为63天(95%CI: 56-70)。
- 各原发部位中位留置时间:鼻咽119天(95%CI: 109-131),口咽57天(95%CI: 51-68),下咽126天(95%CI: 77-256),喉53天(95%CI: 21-63),原发不明30天(95%CI: 17-55)。
- 下咽癌与其他部位相比留置时间差异有统计学意义(p < 0.001)。
关键数值与推荐
- 全部患者接受IMRT,571例(58.4%)接受化疗,698例(71.4%)接受预防性G-tube。
临床怎么用
- 对于接受根治性IMRT的晚期头颈癌患者,应关注放疗后G-tube的长期留存情况。
- 下咽癌患者可能需要更长时间的G-tube支持,应加强营养和吞咽管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our study assessed post-radiation therapy (RT) G-tube presence, duration, and clinical predictors in patients with head and neck cancer (HNC). METHODS: We identified those 1-5-years post-RT with stage III/IV nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or unknown primaries. Logistic regression identified predictors of post-RT G-tube presence, Kaplan-Meier analysis estimated G-tube days, and log-rank test compared by tumor site. RESULTS: The 977 patients had mean age 60.6 ± 11.6 years, 804 (82.3%) male, 764 (78.2%) stage IV, and 618 (63.3%) oropharyngeal primaries. All patients received intensity-modulated RT (IMRT), 571 (58.4%) received chemotherapy, and 698 (71.4%) prophylactic G-tube. G-tube prevalence 1- and 5-years post-IMRT was 7.1% and 4.8%, respectively. Median post-IMRT G-tube days were overall 63 (95%CI: 56-70), nasopharynx 119 (95%CI: 109-131), oropharynx 57 (95%CI: 51-68), hypopharynx 126 (95%CI: 77-256), larynx 53 (95%CI: 21-63), unknown 30 (95%CI: 17-55), of which hypopharynx was highest p < 0.001. CONCLUSIONS: At an institution offering prophylactic G-tube for patients with advanced HNC, no differences were found in yearly G-tube use 1-5 years post-IMRT. Across all patients, median post-IMRT days with G-tube was 63 day but those with hypopharyngeal tumors registered the most days.
引用
- Greco E, Ringash J, Tomlinson G, et al. Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy. Head Neck. 2021. PMID: 33580567. doi:10.1002/hed.26638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。